The Roth Lab focuses on diseases affecting the eyes; more specifically, retinal injury caused by ischemia in conditions including diabetic retinopathy. Retinal ischemia-associated retinal degeneration is one of the leading causes of vision loss, and to this date there are no effective treatment options. We research the molecular, genetic and biochemical mechanisms leading to retinal injury and vision loss using our in-vivo and in-vitro models. Another interesting area of our research is application of stem cells, stem cell conditioned media, and stem cell derived exosomes as a therapeutic strategy. Learn more about our research and read some of our publications.